1. Home
  2. BOC vs FULC Comparison

BOC vs FULC Comparison

Compare BOC & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOC
  • FULC
  • Stock Information
  • Founded
  • BOC 2009
  • FULC 2015
  • Country
  • BOC United States
  • FULC United States
  • Employees
  • BOC N/A
  • FULC N/A
  • Industry
  • BOC
  • FULC Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOC
  • FULC Health Care
  • Exchange
  • BOC Nasdaq
  • FULC Nasdaq
  • Market Cap
  • BOC 413.9M
  • FULC 469.0M
  • IPO Year
  • BOC 2017
  • FULC 2019
  • Fundamental
  • Price
  • BOC $12.94
  • FULC $9.36
  • Analyst Decision
  • BOC Strong Buy
  • FULC Buy
  • Analyst Count
  • BOC 1
  • FULC 7
  • Target Price
  • BOC $25.00
  • FULC $9.14
  • AVG Volume (30 Days)
  • BOC 171.5K
  • FULC 536.5K
  • Earning Date
  • BOC 11-13-2025
  • FULC 10-29-2025
  • Dividend Yield
  • BOC N/A
  • FULC N/A
  • EPS Growth
  • BOC N/A
  • FULC N/A
  • EPS
  • BOC 0.02
  • FULC N/A
  • Revenue
  • BOC $111,568,551.00
  • FULC N/A
  • Revenue This Year
  • BOC $7.79
  • FULC N/A
  • Revenue Next Year
  • BOC $3.80
  • FULC N/A
  • P/E Ratio
  • BOC $624.46
  • FULC N/A
  • Revenue Growth
  • BOC 9.53
  • FULC 2752.05
  • 52 Week Low
  • BOC $12.27
  • FULC $2.32
  • 52 Week High
  • BOC $16.20
  • FULC $10.11
  • Technical
  • Relative Strength Index (RSI)
  • BOC 38.27
  • FULC 54.41
  • Support Level
  • BOC $13.69
  • FULC $8.89
  • Resistance Level
  • BOC $13.97
  • FULC $10.09
  • Average True Range (ATR)
  • BOC 0.31
  • FULC 0.70
  • MACD
  • BOC -0.08
  • FULC -0.04
  • Stochastic Oscillator
  • BOC 0.00
  • FULC 59.44

About BOC Boston Omaha Corporation

Boston Omaha Corp is a United States based company which invests in real estate. Its operations include its ownership of multiple billboards in Florida, Georgia, Wisconsin, and Alabama and equity method investments in several real estate companies. The company operates four separate lines of business, outdoor billboard advertising, the broadband services industry, the insurance industry, and the asset management industry. Company generate revenue from outdoor advertising through the leasing of advertising space on billboards. It also generate revenue from commissions on surety bond sales and account for commissions and principally from internet services and is recognized on a straight-line basis over the term of the contract in the period the services are rendered.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: